Stock comparison
Alignment Healthcare
Haemonetics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ALHC
Alignment Healthcare
Market cap
$3.38B
Sector
Healthcare
HAE
Haemonetics
Market cap
$2.98B
Sector
Healthcare
Overall winner
Haemonetics HAE
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ALHC | HAE | Winner |
|---|---|---|---|
| Warren Buffett | 34F | 70B | HAE |
| Benjamin Graham | 68D | 85A | HAE |
| Philip Fisher | 46D | 60C | HAE |
| Peter Lynch | 66B | 54C | ALHC |
| Joel Greenblatt | 43D | 31F | ALHC |
| Charlie Munger | 36D | 54D | HAE |
| Terry Smith | 33F | 55D | HAE |
Side-by-side metrics
| Metric | ALHC | HAE |
|---|---|---|
| Market cap | $3.38B | $2.98B |
| P/E (TTM) | 186.4x | 24.8x |
| EV/EBIT | 178.7x | 14.1x |
| ROIC (TTM) | 5.88% | 8.37% |
| Gross margin | 12.38% | 55.74% |
| Net margin | 0.47% | 7.29% |
| Revenue CAGR 5y | 35.6% | 7.65% |
| EPS CAGR 5y | - | 24.62% |
| Debt / Equity | 1.6x | 1.5x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ALHC leads on
- Revenue CAGR 5y35.6%vs 7.65%+79%
- Market cap$3.38Bvs $2.98B+12%
HAE leads on
- Net margin7.29%vs 0.47%+94%
- EV/EBIT14.1xvs 178.7x+92%
- P/E (TTM)24.8xvs 186.4x+87%
- Gross margin55.74%vs 12.38%+78%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.